Department of Neurology, Neurosciences Institute, Atrium Health, Charlotte, North Carolina, United States of America.
Information and Analytics Services, Atrium Health, Charlotte, North Carolina, United States of America.
PLoS One. 2024 Nov 18;19(11):e0309163. doi: 10.1371/journal.pone.0309163. eCollection 2024.
Stroke patients with large core infarctions benefit from endovascular intervention, though only approximately 20% are functionally independent at 90 days. We studied prognostic factors for patients presenting with a large computed tomography perfusion (CTP) core.
Retrospective analysis from a health system stroke registry, including consecutive thrombectomy patients treated within 24 hours from August 2020-December 2022 with an anterior circulation large vessel occlusion and CTP core infarct ≥50 milliliters. Logistic regression was used to determine independent predictors of 90-day modified Rankin Scale (mRS) score 4-6. The prognostic ability of previously reported scales was also assessed.
In 118 included patients, with mean age 64.3 ± 14.1 years, poor functional outcomes were present in 66 subjects (55.9%). The multivariable regression analysis demonstrated that higher presenting National Institutes of Health Stroke Scale (NIHSS) score (odds ratio [OR] 1.12, 95% confidence interval [CI] 1.02-1.23, p = 0.014), elevated glucose (OR 1.02, 95% CI 1.01-1.03, p = 0.002), absence of treatment with intravenous thrombolysis (OR 4.01, 95% CI 1.35-11.95, p = 0.013), and poor revascularization (OR 4.76, 95% CI 1.24-18.37, p = 0.023) were independently associated with primary outcome. The Charlotte Large artery occlusion Endovascular therapy Outcome Score (CLEOS) predicted 90-day mRS 4-6 (per 25-point increase, OR 1.22, 95% CI 1.10-1.34, p<0.001) and mRS 5-6 (per 25-point increase, OR 1.21, 95% CI 1.10-1.33, p<0.001). Nineteen of 20 (95%) patients with CLEOS ≥ 675 had 90-day mRS scores of 4-6, while 10 of 12 (83.3%) with CLEOS ≥ 725 had 90-day mRS scores of 5-6.
We report prognostic factors that can risk stratify thrombectomy patients with large CTP core infarctions.
尽管只有约 20%的大核心梗死的中风患者在 90 天内达到独立功能,但血管内介入治疗对其有益。我们研究了大计算机断层灌注 (CTP) 核心的中风患者的预后因素。
这是一项来自健康系统中风登记处的回顾性分析,纳入了 2020 年 8 月至 2022 年 12 月期间接受治疗的连续接受血栓切除术的前循环大血管闭塞且 CTP 核心梗死大于 50 毫升的患者。使用逻辑回归确定 90 天改良 Rankin 量表 (mRS) 评分 4-6 的独立预测因素。还评估了先前报道的量表的预后能力。
在纳入的 118 名患者中,平均年龄为 64.3±14.1 岁,66 名患者(55.9%)存在不良功能结局。多变量回归分析表明,较高的初始国立卫生研究院中风量表 (NIHSS) 评分(比值比 [OR] 1.12,95%置信区间 [CI] 1.02-1.23,p=0.014)、高血糖(OR 1.02,95%CI 1.01-1.03,p=0.002)、未接受静脉溶栓治疗(OR 4.01,95%CI 1.35-11.95,p=0.013)和较差的血管再通(OR 4.76,95%CI 1.24-18.37,p=0.023)与主要结局独立相关。夏洛特大动脉闭塞血管内治疗结局评分(CLEOS)预测 90 天 mRS 4-6(每增加 25 分,OR 1.22,95%CI 1.10-1.34,p<0.001)和 mRS 5-6(每增加 25 分,OR 1.21,95%CI 1.10-1.33,p<0.001)。20 名 CLEOS≥675 分的患者中有 19 名(95%)在 90 天内的 mRS 评分达到 4-6,而 12 名 CLEOS≥725 分的患者中有 10 名(83.3%)达到 90 天的 mRS 评分 5-6。
我们报告了可以对大 CTP 核心梗死的血栓切除术患者进行风险分层的预后因素。